 |
Hsp90 as a therapeutic target in renal cancer. |
 |
|
 |
Hsp90-dependent regulation of EphA2 and cell migration in prostate cancer and glioblastoma. |
|
|
 |
Project 3: Inhibition of cell surface localized Hsp90 as a means to curtail cell migration and metastatic spread. |